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The establishment of persistent noncytopathic replication by replicon RNAs of a number of positive-strand
RNA viruses usually leads to generation of adaptive mutations in nonstructural genes. Some of these adaptive
mutations (e.g., in hepatitis C virus) increase the ability of RNA replication to resist the antiviral action of
alpha/beta interferon (IFN-/); others (e.g., in Sindbis virus) may also lead to more efficient IFN production.
Using puromycin-selectable Kunjin virus (KUN) replicon RNA, we identified two adaptive mutations in the
NS2A gene (producing Ala30-to-Pro and Asn101-to-Asp mutations in the gene product; for simplicity, these will
be referred to hereafter as Ala30-to-Pro and Asn101-to-Asp mutations) that, when introduced individually or
together into the original wild-type (wt) replicon RNA, resulted in 15- to 50-fold more efficient establishment
of persistent replication in hamster (BHK21) and human (HEK293 and HEp-2) cell lines. Transfection with
a reporter plasmid carrying the luciferase gene under the control of the IFN- promoter resulted in 6- to
7-fold-higher luciferase expression in HEp-2 cells stably expressing KUN replicon RNA with an Ala30-to-Pro
mutation in the NS2A gene compared to that observed in HEp-2 cells stably expressing KUN replicon RNA
with the wt NS2A gene. Moreover, cotransfection of plasmids expressing individual wt or Ala30-to-Pro-mutated
NS2A genes with the IFN- promoter reporter plasmid, followed by infection with Semliki Forest virus to
activate IFN- promoter-driven transcription, showed7-fold inhibition of luciferase expression by the wt but
not by the Ala30-to-Pro-mutated NS2A protein. The results show for the first time a role for the flavivirus
nonstructural protein NS2A in inhibition of IFN- promoter-driven transcription and identify a single-amino-
acid mutation in NS2A that dramatically reduces this inhibitory activity. The findings determine a new
function for NS2A in virus-host interactions, extend the range of KUN replicon vectors for noncytopathic gene
expression, and identify NS2A as a new target for attenuation in the development of live flavivirus vaccines.
Kunjin virus (KUN) is an Australian flavivirus closely related to
other members of the Japanese encephalitis virus subgroup, in-
cluding the New York strain of West Nile virus (WNV). The
KUN genome consists of single-stranded RNA of positive polar-
ity comprising 11,022 nucleotides (29), with one long open read-
ing frame coding for 3,433 amino acids in three structural proteins
(C, prM, and E) and seven nonstructural (NS) proteins (NS1,
NS2A, NS2B, NS3, NS4A, NS4B, and NS5) (7). The gene order
of KUN genome RNA is 5-C-(pr)M-E-NS1-NS2A-NS2B-NS3-
NS4A-NS4B-NS5-3. We previously constructed the first flavivi-
rus replicons based on KUN cDNA by deleting the majority of
the genomic region including structural genes (30) and used them
extensively for the development of a gene expression system (2,
19, 28, 30, 44, 45). KUN replicons were also used extensively in
RNA replication and complementation studies (23–27, 32) that
contributed substantially to generating a comprehensive model
for the formation and operation of the flavivirus RNA replication
complex (47, 48).
The establishment of persistent noncytopathic replication by
replicon RNAs of a number of positive-strand RNA viruses
was shown to lead to the generation of adaptive mutations in
nonstructural genes that either decreased (alphavirus repli-
cons) or enhanced (hepatitis C replicons) RNA replication
efficiency (1, 4, 13, 14, 34, 39, 41, 50). Some of these adaptive
mutations (e.g., in the NS5A protein of the hepatitis C repli-
con) were shown to increase the ability of RNA replication to
resist the antiviral action of alpha/beta interferon (IFN-/)
(41), while others (e.g., in the nsP2 protein of Sindbis virus)
were shown to lead to more efficient IFN production (14). IFN
response is the first line of cell defense against viral infections,
and a majority of viruses have developed various strategies to
overcome it, by either inhibiting IFN production or blocking
IFN signaling (15, 22, 35, 43). Recent studies of dengue virus
have indicated that flaviviruses may interfere with early steps
of IFN signaling and have implied roles for the small nonstruc-
tural proteins NS2A, NS4A, and NS4B in this process (37).
In this study, we describe the identification of adaptive mu-
tations in KUN replicon RNA that confirm an advantage in
establishing persistent replication in a number of different cell
lines. We also demonstrate that induction of IFN- promoter-
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driven transcription is severely inhibited in cells expressing
replicon RNA with the native sequence, while no such inhibi-
tion is observed in cells expressing replicon RNA with an
adaptive mutation in the NS2A protein. Similarly, wild-type
(wt) but not mutated NS2A protein, when expressed individ-
ually, inhibits induction of IFN- promoter-driven transcrip-
tion. Our findings demonstrate a novel role for the flavivirus
NS2A protein in inhibition of the cellular antiviral response,
extend the range of KUN replicon vectors for noncytopathic
gene expression, and identify NS2A as a new target for atten-
uation in the development of a KUN-based vaccine against a
closely related emerging human pathogen, the New York
strain of West Nile virus.
MATERIALS AND METHODS
Cells and viruses. BHK21, Vero, HEK293, and HEp-2 cells were grown in
Dulbecco’s modification of minimal essential medium (DMEM) (Invitrogen,
Carlsbad, Calif.) supplemented with 10% fetal bovine serum at 37°C in a CO2
incubator. BHK and HEp-2 cells stably expressing KUN replicon RNAs were
maintained in the same medium supplemented with 1 to 5 g of puromycin
(Sigma Aldrich, St. Louis, Mo.) per ml. Vero cells are known to have a deletion
of the IFN- gene (36), and BHK21 cells also appear to have a defect in IFN
production (38).
KUN virus strain MRM61C (46) was propagated in suckling mouse brain and
titrated in Vero cells. Semliki Forest virus (SFV) was kindly provided by Nigel
McMillan (Center for Immunology and Cancer Research, University of Queens-
land) and propagated and titrated in Vero cells.
Construction of the plasmids. A construct, repPAC–-Gal, encoding KUN
replicon cDNA with the wild-type KUN sequence, the puromycin resistance gene
(PAC), and a reporter gene, -galactosidase (-Gal), was described previously
(32) and was used to generate replicons with adaptive mutations in NS2A (Ala30
to Pro and Asn101 to Asp) and in NS5 (Pro270 to Ser) by site-directed PCR
mutagenesis using high-fidelity Pfu DNA polymerase (Stratagene, La Jolla,
Calif.) and appropriate primers. Mutagenesis was initially performed using in-
termediate plasmids containing smaller fragments from NS2A or NS5 gene
regions cloned in the pUC18 vector. After confirmation of the introduced mu-
tations by sequencing analysis, the fragments from the intermediate plasmids
containing the individual mutations were used to replace corresponding frag-
ments in repPAC–-Gal to generate the plasmids NS2A/A30P, NS2A/N101D,
and NS5/P270S, respectively. The plasmids NS2A/A30P/N101D, NS2A/
A30P_NS5/P270S, and NS2A/A30P/N101D_NS5/P270S containing combined
mutations in the NS2A and NS5 genes were generated from the plasmids con-
taining individual mutations by substituting corresponding fragments. All muta-
tions in the resulting constructs were confirmed by sequencing. Plasmid
pcDNA3-wtNS2A expressing the wt NS2A cassette, containing the last 22 codons
of E, the first 3 and the last 50 codons of NS1, and the full-length NS2A gene
fused at the C terminus with 9 codons of the c-Myc epitope, was generated by
cloning the corresponding DNA fragment obtained by PCR from FLSDXdNS1.1
DNA (26) into the pcDNA3 vector (Invitrogen) using high-fidelity Pfu DNA
polymerase and appropriate primers. Plasmid pcDNA3-NS2A/A30P was con-
structed from pcDNA3-wtNS2A by site-directed PCR mutagenesis using high-
fidelity Pfu DNA polymerase and appropriate primers. Further details of the
plasmid constructions can be obtained upon request.
RNA transcription, electroporation, and generation of cell lines stably ex-
pressing KUN replicon RNA. All RNA transcripts were prepared with SP6 RNA
polymerase from XhoI-linearized plasmid DNAs and electroporated into
BHK21 cells, essentially as described previously (30). Briefly, 10 g of in vitro-
transcribed RNAs were electroporated into 2  106 BHK21 (normal BHK) cells
in 400 l in a 0.2-cm electrode gap cuvette (Bio-Rad) in a Bio-Rad Gene Pulser
II apparatus. The electroporated cells were split into two aliquots, and one of the
aliquots was seeded undiluted into a 60-mm-diameter dish. Two days after
electroporation, the cells were harvested to isolate total RNA in order to analyze
transient RNA replication and accumulation by Northern blotting. The cells in a
second aliquot were serially (10-fold) diluted with 10% fetal calf serum-DMEM
and seeded onto 60-mm-diameter dishes. Two days after electroporation, 5 g of
puromycin/ml was added to the medium, and the cells were propagated for an
additional 7 days. Puromycin-resistant cell colonies in one of the dishes with
appropriate dilution were visualized by staining them with crystal violet, while
cell colonies in a parallel dish were isolated by using cloning cylinders (Medos,
Brisbane, Australia) and propagated further in the puromycin-containing me-
dium to generate cell lines stably expressing KUN replicon RNA (Fig. 1). In
other experiments (see Fig. 3 to 5) stable cell lines were generated by the
selection of a total population of RNA-transfected or virus-like particle (VLP)-
infected cells in the puromycin-containing medium.
X-Gal staining, -galactosidase assay, and Northern blotting. Detection of
replication and expression of mutated replicon RNAs in BHK-21 cells was
performed by in situ staining with 5-bromo-4-chloro-3-indolyl--D-galactopyr-
anoside (X-Gal), by -Gal assay of lysed cells using a -galactosidase enzyme
assay kit (Promega, Madison, Wis.) essentially as described by the manufacturer
or by Northern blotting with 32P-labeled probes specific for -Gal and -actin
nucleotide sequences, as described previously (32).
Packaging of KUN replicon RNAs into virus-like particles. In vitro-tran-
scribed KUN replicon RNAs containing adaptive mutations were electroporated
into the tetKUNCprME packaging cell line essentially as described previously
(20). Electroporated cells were cultured in 100-mm-diameter dishes, and the cell
FIG. 1. -Galactosidase expression from KUN replicon RNA in different puromycin-resistant BHK21 cell clones. BHK21 cells were electro-
porated with the repPAC–-Gal replicon RNA and subjected to selection during passages in medium containing 5 g of puromycin/ml as described
in Materials and Methods. Individual puromycin-resistant cell colonies were isolated and propagated in puromycin-containing DMEM. The cells
were lysed and assayed for -galactosidase expression at passage 4 (A) and passage 7 (B). The error bars represent standard deviations calculated
from the -Gal expression determined in two wells used for each -Gal assay.
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culture fluid was harvested 2, 4, 6, and 8 days after electroporation. The titers of
secreted VLPs containing encapsidated replicon RNAs were determined by
infecting Vero cells and staining them with X-Gal 48 h after infection.
RNA isolation, RT-PCR, and sequencing. Total RNAs from KUN replicon-
expressing cell lines were purified by using an Absolutely RNA reverse transcrip-
tion (RT)-PCR miniprep kit (Stratagene) as described by the manufacturer.
cDNA synthesis and PCR amplification were performed with a SuperScript
one-step RT-PCR kit (Invitrogen) using 1 g of purified total RNA and appro-
priate primers. Briefly, The RT-PCR mixture (50 l) containing all necessary
components was incubated at 50°C for 30 min for cDNA synthesis by reverse
transcriptase, and the following 25 cycles of PCR amplification were performed:
95°C for 30 s, 56°C for 30 s, and 72°C for 2 to 4 min according to the length of
the PCR fragments. Sequencing of plasmid DNAs and of PCR fragments was
performed by using a DNA-sequencing kit (Perkin-Elmer, Wellesley, Mass.) as
described by the manufacturer.
RESULTS
Adaptation of Kunjin replicon RNA to persistent replication
in BHK21 cells resulted in the selection of replicons with
mutations in NS2A and NS5 genes. In previous studies, it was
noticed that KUN replicons with the native KUN sequence
induced some cytopathicity in BHK cells compared to our
originally developed noncytopathic replicons (2) that were
later found to contain a mutation in the NS1 gene producing a
Pro250-to-Leu mutation in NS1 (17) (for simplicity, such mu-
tations will be referred to hereafter as, e.g., Pro250-to-Leu
mutations). This mutation was shown to abolish NS1 dimer
formation, to delay virus replication in Vero cells, and to at-
tenuate virus replication in weanling mice (17). Incorporation
of this mutation in the puromycin-selectable and -galactosi-
dase-encoding KUN replicon RNA repPAC–-Gal (32)
showed some delay in RNA replication in transient transfec-
tions and a moderate (two- to threefold) increase in the num-
ber of puromycin-resistant cell colonies after puromycin selec-
tion (data not shown). In this study, we aimed at identifying
additional mutations in the KUN nonstructural proteins that
would allow more efficient establishment of persistent replica-
tion of KUN replicon RNA. To achieve this, we established a
panel of repPAC–-Gal-expressing BHK cell clones that were
able to grow in the presence of 5 g of puromycin per ml. The
efficiencies of RNA replication and expression in each of the
17 established cell clones at passage 4 were analyzed by -Gal
expression. The -Gal expression varied from 0.95 to 8.15
mU/104 cells between the individual cell clones (Fig. 1A), and
a noticeable difference in the cell growth rates between differ-
ent cell clones was observed (data not shown). X-Gal staining
also showed variation in the intensity of staining, with clone 20
exhibiting the highest intensity in individual cells (not shown).
We selected the rapidly growing cell clone 11 (with the highest
-Gal expression) (Fig. 1A) and the slowly growing clone 20
(with the most intensive X-Gal staining) for further passaging
and compared levels of -Gal expression at passage 7. In con-
trast to the results at passage 4, by passage 7, clone 20 showed
1.5-fold-higher -Gal expression than clone 11 (Fig. 1B).
Both clones at passage 7 now propagated with similar growth
rates (not shown). Sequencing analysis of the entire KUN
replicon cDNA (excluding the -Gal gene) obtained by reverse
transcription and PCR of total cell RNA isolated from these
cell clones at passage 7 identified two mutations (Ala30 to Pro
in NS2A and Pro270 to Ser in NS5) in clone 11 (Table 1) and
one mutation (Asn101 to Asp in NS2A) in clone 20 (Table 1).
It is possible that the differences between the levels of -Gal
expression in these two cell lines observed at passages 4 and 7
could be due to a better adaptation of propagated cells to
replicating KUN replicon RNA, leading to more rapid cell
growth and thus to higher expression and accumulation of
-Gal. It is also possible that the variations in expression levels
between the passages could be explained by the different stages
of the cell cycle at the time of harvesting.
Effects of adaptive mutations on initiation and efficiency of
replicon RNA replication in BHK cells in transient-transfec-
tion studies. Each of the adaptive mutations was introduced
individually or in various combinations into the original rep-
PAC–-Gal replicon, and their effects on initiation and the
level (efficiency) of RNA replication were initially tested in
transient (2-day) transfection experiments by using X-Gal
staining and Northern blot analyses. Ala30-to-Pro mutation in
NS2A (NS2A/A30P, as in clone 11) did not significantly affect
the number of positively stained cells and the level of accumu-
lated replicon RNA (Fig. 2). In fact, the relative levels of
accumulated KUN RNA normalized to the levels of host cell
(-actin) mRNA were the same for transfected wt and NS2A/
A30P RNAs (100 and 104%, respectively). Asn101-to-Asp mu-
tation in NS2A (NS2A/N101D, as in clone 20), however, re-
sulted in some decrease in the number of positively stained
cells (Fig. 2A) and a corresponding decrease in the level of
accumulated replicon RNA (72% of the wt RNA) (Fig. 2B). A
combination of adaptive mutations in NS2A resulted in some
further decrease in the number of X-Gal-positive cells and in
the level of accumulated RNA (55% of the wt RNA) (Fig. 2).
Since the number of positively stained cells after transfection
of the last two mutant RNAs was also lower than after trans-
fection with the wt or Ala30-to-Pro-mutated RNAs (Fig. 2A),
it is likely that Asn101-to-Asp mutation in NS2A affected the
initiation of replicon RNA replication, thus leading to a cor-
responding decrease in the total levels of accumulated RNA
detected in Northern blotting. The Pro270-to-Ser mutation in
NS5 (NS5/P270S, as in clone 11) had the most profound in-
hibitory effect on initiation of replicon RNA replication, as
judged by the substantially lower number of positive cells and
the low total level of accumulated RNA (only 12% of the wt
RNA) (Fig. 2).
When NS5 mutation was combined with the other two mu-
tations in NS2A, the resulting replicon RNA was far less effi-
cient in initiation of RNA replication, as judged from the
results of X-Gal staining (Fig. 2A) and Northern blot analysis
(Fig. 2B). Somewhat surprisingly, combination of Pro270-to-
Ser mutation in NS5 with a single Ala30-to-Pro mutation in
NS2A did not produce a similar profound inhibitory effect, as
would be expected from the presence of a highly inhibitory
TABLE 1. Identification of cell-adaptive mutations in KUN
replicon RNA
Gene
Nucleotide
position in
genome
Amino
acid
position
in gene
Wild-type
nucleotide/
amino acid
Clone 11
nucleotide/
amino acid
Clone 20
nucleotide/
amino acid
NS2A 3613 30 G/Ala C/Pro
NS2A 3826 101 A/Asn G/Asp
NS5 8488 270 C/Pro T/Ser
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NS5 mutation (Fig. 2). This suggests that Ala30-to-Pro muta-
tion in NS2A may have some compensatory effect on mutation
in NS5. Similarly, different degrees of cooperativity of various
adaptive mutations in increasing the efficiency of replication of
HCV replicon RNAs in transient-transfection studies were
observed (33). The results show that (i) Ala30-to-Pro adaptive
mutation in NS2A did not affect the initiation of replication of
KUN RNA, (ii) Asp101-to-Asn adaptive mutation in NS2A
slightly reduced the efficiency of initiation of RNA replication,
(iii) Pro270-to-Ser adaptive mutation in NS5 significantly re-
duced the efficiency of initiation of RNA replication, and (iv)
different combinations of the adaptive mutations resulted in
various and not always predictable reductions of efficiency of
initiation of RNA replication.
Replicon RNAs with adaptive mutations in NS2A are more
efficient in establishing persistent replication in BHK cells.
The dilutions of BHK cells corresponding to 20 ng of each
replicon RNA containing either individual or combined adap-
tive mutations in NS2A and NS5 (from the experiment shown
in Fig. 1) were propagated in medium with 5 g of puromy-
cin/ml for 7 days, followed by staining with crystal violet.
Seventeen- and 13-fold increases in the number of puromycin-
resistant cell colonies relative to transfections with the wild-
type KUN replicon were observed for RNAs with NS2A/A30P
and NS2A/N101D mutations, respectively (Fig. 3). Interest-
ingly, combination of two adaptive mutations in NS2A resulted
in a slightly higher (21-fold) increase in the number of puro-
mycin-resistant colonies compared to the increase when these
mutations were introduced separately (Fig. 3). It is reasonable
to assume that the substantial increase in the number of pu-
romycin-resistant cell colonies observed for RNAs with indi-
vidual or combined mutations in NS2A is due to the decreased
cytopathicity of mutated RNAs, since the initial number of
X-Gal-positive cells prior to puromycin selection were either
similar (NS2A/A30P and NS2A/A30P_N101D) or only slightly
lower (NS2A/N101D) than that of the wt RNA (Fig. 1A).
Only a 1.8-fold increase was observed for RNA with the
NS5/P270S mutation (Fig. 3). Given the substantially lower
number of X-Gal-positive cells detected after transfection of
NS5/P270S RNA prior to puromycin selection compared to
that with the wt RNA (Fig. 1A), the recovery of a similar or
slightly higher number of puromycin-resistant cell clones sug-
gests that despite having a defect in the initiation of RNA
replication, NS5/P270S replicon RNA also appears to be less
cytopathic. Therefore, Pro270-to-Ser adaptive mutation in NS5
appears to decrease both the efficiency of initiation of RNA
replication and its cytopathicity.
Combined adaptive mutations in NS2A and NS5 produced
variable effects on the efficiency of establishment of persistent
replication. For example, a combination of NS2A/A30P and
NS5/P270S mutations (as in clone 11) resulted in a 12.5-fold
increase in the number of puromycin-resistant colonies (Fig.
3), while replicon RNA with all three adaptive mutations (two
in NS2A and one in NS5) was not more efficient than the wt
RNA in establishing persistent replication (Fig. 3). It is not
clear why some combinations of adaptive mutations had a
cooperative effect (e.g., Ala 30 to Pro and Asn101 to Asp in
NS2A) while other combinations did not (e.g., Asn101 to Asp
in NS2A and Pro270 to Ser in NS5, or all three mutations).
Interestingly, various combinations of adaptive mutations in
HCV replicon RNA also did not always cooperate in improv-
ing the efficiency of establishing persistent replication, as ex-
pected from the effects of individual mutations (34). Neverthe-
less, our results clearly demonstrated an advantage of adaptive
mutations in NS2A, either alone or in combination, in estab-
lishing persistent replication of KUN replicon RNA in BHK
cells.
FIG. 2. Comparison of replication efficiencies of KUN replicon
RNAs with different cell-adaptive mutations in transient transfections.
BHK21 cells were electroporated with replicon RNAs with different
cell-adaptive mutations. (A) Forty-eight hours after electroporation,
the cells were stained with X-Gal to detect cells positive for expression
of -galactosidase from KUN replicon RNA. (B) Total RNA (10 g)
isolated from electroporated cells was used for analysis of the accu-
mulation of replicating RNA by Northern blotting with 32P-labeled
probes specific for KUN replicon RNA (top) or for -actin mRNA
(bottom). The arrows indicate positions in the gel of RNAs of 12.5 (top
row) and 1.1 (bottom row) kb determined relative to migration in the
same gel of the ethidium bromide-stained 1-kb Plus ladder (Invitro-
gen). Normalized KUN RNA levels show percentages of RNA levels
from the wt RNA (100%) normalized to the levels of -actin mRNA.
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Replication efficiencies of RNAs with adaptive mutations
are similar in established stable BHK cell lines. BHK cells
(total cell population) transfected with the wt or each of the
mutated replicon RNAs were propagated in medium with 5 g
of puromycin/ml for four passages during a total period of 20
days of culture, and the efficiency of RNA replication and
expression in established cells was examined by Northern blot-
ting of total cell RNA and by -Gal assay of cell lysates,
respectively. In contrast to significant differences in replication
and expression efficiencies between different mutant RNAs
observed in transient RNA transfection studies of 2 days du-
ration, the efficiencies of RNA replication and expression in
established stable cell lines cultured for 20 days at passage 4
were relatively similar, with a maximum of only a 1.5-fold
difference in -Gal expression between different cell lines (Fig.
4). RT-PCR and sequencing analysis of replicon RNAs con-
firmed the retention of introduced adaptive mutations (not
shown), thus confirming the genetic stability of RNAs with
introduced adaptive mutations during the selection process.
Similarly, RT-PCR and sequencing analysis of replicon RNA
isolated from puromycin-resistant cells established from a total
population of cells transfected with the wt KUN replicon RNA
showed no mutations in the NS2A and NS5 genes in which
adaptive mutations were previously identified. It seems likely
that the dominant RNA species initially present in the RNA
pool used for transfections are maintained during the selection
process when a total cell population rather than the clonal cell
selection is used for establishing stably expressing replicon cell
lines. However, further sequencing analysis is required to
reach a definite conclusion about the absence of any additional
adaptive mutations in the remaining replicon sequence which
may arise during the selection process. The results so far sug-
gest that in the process of selection, cells down- or up-regu-
lated KUN RNA replication and expression to a certain
threshold level that does not harm cellular machinery. Once
stable expression is established, this equilibrium between rep-
licon RNA and the surviving cell appears to be maintained by
ensuring the replication of different replicon RNAs (with or
without adaptive mutations) at a similar level.
Packaging of KUN replicon RNAs with adaptive mutations
into virus-like particles. A previous report showed that Sindbis
virus and SFV replicon RNAs with some of the adaptive (non-
cytopathic) mutations in nsP2 could not be packaged efficiently
into VLPs, while those RNAs with other adaptive mutations in
nsP2 could (39). We examined the packaging abilities of KUN
replicon RNAs with adaptive mutations by transfecting them
into a recently reported tetracycline-inducible packaging BHK
cell line, tetKUNCprME (20). The secreted VLPs were har-
vested every 2 days for 6 to 8 days, and the VLP titers were
FIG. 3. Cell-adaptive mutations confer an advantage in establishing persistent replication of KUN replicon RNA in BHK21 cells. BHK21 cells
were electroporated with replicon RNAs containing different cell-adaptive mutations (as in Fig. 2). Forty-eight hours after electroporation,
medium with 5 g of puromycin/ml was added, and the cells were propagated for an additional 7 days. Puromycin-resistant cell colonies were fixed
in 4% formaldehyde and stained by crystal violet in phosphate-buffered saline.
FIG. 4. Characterization of replication and expression of KUN
replicon RNAs with different adaptive mutations in established puro-
mycin-resistant BHK cell lines. Stably expressing BHK21 cell lines
were established after electroporation with KUN replicon RNAs con-
taining different adaptive mutations as described in Materials and
Methods. At passage 4, cells from each established cell line were
analyzed for -galactosidase expression (A) and for accumulation of
replicating KUN RNA by Northern blotting with 32P-labeled probes
specific for KUN replicon RNA (B, top) or for -actin mRNA (B,
bottom). The error bars in panel A represent standard deviations
calculated from the -Gal expression determined in two wells used for
each -Gal assay. In panel B, 10 g of total RNA was used for
hybridization; the arrows indicate positions in the gel of RNAs of 12.5
(top) and 1.1 (bottom) kb determined relative to migration in the same
gel of the ethidium bromide-stained 1-kb ladder (Invitrogen).
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determined as described in Materials and Methods. Replicon
RNA with the NS2A/A30P mutation was packaged with effi-
ciency similar to that of the wt RNA; the other mutant RNAs
suffered a 50- to 500-fold decrease in packaging efficiency on
day 2, but all except the RNA with combined mutations in
NS2A recovered packaging efficiency close to the wild type by
day 6 (Table 2). The RNA with combined mutations in NS2A
was still packaged 40-fold less efficiently than the wild-type
RNA by day 8. RT-PCR and sequencing analysis of KUN
replicon RNAs isolated from secreted VLPs harvested on day
6 after transfection showed retention of all the corresponding
adaptive mutations, thus excluding reversion to the wt se-
quence as a possible reason for the improved packaging effi-
ciency later in transfection. It is therefore likely that the im-
proved packaging efficiency later in transfection (days 6 to 8) of
the initially inefficiently packaged replicon RNAs was largely
due to the spread and accumulation of VLPs in packaging
cells. Since the number of cells does not increase once they
reach confluency, less efficiently packaged replicons will even-
tually catch up with more efficiently packaged replicons by
spreading to all available packaging cells via VLP infection. At
the same time, the number of VLPs will not increase for the
more efficiently packaged replicons, since once they spread to
all the cells early in transfection, there will be no more cells
available for VLPs to spread to. However, the possibility of the
occurrence of additional adaptive mutations elsewhere in the
replicon genome that may improve the packaging efficiency of
initially poorly packaged RNAs cannot be completely ruled out
without further confirmation by sequencing analysis of entire
replicon genomes. Nevertheless, we can conclude that at least
the NS2A/A30P mutation did not affect the packaging effi-
ciency of replicon RNA, while other mutations appeared to
inhibit the packaging efficiencies of replicon RNAs early in
transfection and replication.
Adaptive mutations in NS2A confer an advantage in estab-
lishing persistent replication in human cell lines. We next
examined whether the adaptive mutations in NS2A shown to
provide an advantage in establishing persistent replication in
the hamster cell line, BHK21, would also provide a similar
advantage in other cell lines, particularly human cell lines.
Monolayers of two human cell lines, HEK293 and HEp-2, were
infected with VLPs containing packaged wt and mutated rep-
licon RNAs at multiplicities of infection (MOIs) of 1 and 10,
respectively (titrated on Vero cells), and propagated for 7 days
in medium with 1 g of puromycin/ml. X-Gal staining of pu-
romycin-resistant colonies showed a 50-fold increase in the
number of colonies relative to the wild-type replicon for the
NS2A/A30P mutant and 20-fold increase for the NS2A/
N101D mutant in both HEK293 and HEp-2 cells (Fig. 5).
Similar differences between the numbers of puromycin-resis-
tant colonies in the wt and NS2A-mutated replicon RNAs were
observed in BHK cells after infection with replicon VLPs at an
MOI of 0.01 (Fig. 5). Interestingly, infection of HEK293 and
HEp-2 cells required 10- and 100-fold more VLPs, respec-
tively, to produce numbers of puromycin-resistant colonies
similar to those produced in BHK21 cells (Fig. 5). Similar
differences between these cell lines were observed in the effi-
ciency of replication of wild-type KUN (not shown). In sepa-
rate experiments, 20-fold more efficient replication of wild-
type KUN was observed in Vero cells than in BHK cells
(results not shown). It is not clear at present whether the
differences in efficiencies of replicon and virus replication in
different cell lines are due to differences in initial attachment
of VLPs and virions to the cell surface or in the initiation
and/or efficiency of RNA replication. Nevertheless, the results
confirmed the advantage of replicon RNAs with adaptive mu-
tations in NS2A in establishing persistent replication in differ-
ent cell lines. Further propagation of replicon VLP-infected
BHK, Vero, HEK293, and HEp-2 cells (total cell population)
in selective medium with puromycin resulted in the establish-
ment of cells stably expressing wt and NS2A-mutated replicon
RNAs, with retention of mutations confirmed by sequencing
(not shown). In all the experiments with BHK, Vero, HEK293,
and HEp-2 cells, the NS2A/A30P mutation allowed more ef-
ficient and quicker establishment of stably expressing cell lines
(results not shown). In agreement with the results in BHK cells
TABLE 2. Packaging efficiencies of KUN replicon RNAs with
different cell-adaptive mutations
Mutation
Packaging efficiency (PFu/ml) on day:
2 4 6 8
Wt 5  106 1.3  108 1.8  108 3.3  108
NS2A/A30P 4  106 1  108 3.4  108 6  108
NS2A/N101D 4.4  104 1.3  107 4  107 NDa
NS5/P270S 1.0  105 6  107 1.3  108 ND
NS2A/A30P/N101D 1  104 1.1  105 1.2  106 9  106
a ND, not determined.
FIG. 5. Adaptive mutations confer advantage in establishing per-
sistent replication of KUN replicon RNA in BHK21, HEp-2, and
HEK293 cells after infection with replicon VLPs. BHK21, HEK293,
and HEp-2 cells were infected with wild-type repPAC–-Gal replicon
VLPs or each of the NS2A mutants at MOIs of 0.01, 1, and 10,
respectively. At 48 h postinfection, 1 (HEK293 and HEp-2) and 5
(BHK21) g of puromycin/ml were added to the medium, and the cells
were propagated for an additional 7 days. Puromycin-resistant cell
colonies were fixed in 4% formaldehyde and stained either with crystal
violet (BHK21) or with X-Gal (HEK293 and HEp-2).
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(Fig. 4), the efficiencies of RNA replication and -Gal expres-
sion in established puromycin-resistant cell lines in HEp-2 and
HEK293 cells stably expressing different replicon RNAs were
also similar (results not shown).
Activation of IFN- promoter-driven transcription is inhib-
ited in cells stably or transiently transfected with KUN repli-
con RNAs containing the wt but not the mutated NS2A gene.
Previous studies showed that infection of NIH 3T3 cells with
Sindbis virus containing an adaptive mutation in nsP2 that
reduced the cytopathicity of Sindbis replicon RNA led to high
levels of alpha/beta IFN production in contrast to the low
levels of IFN produced by infection with virus containing wt
nsP2 (14), thus indicating a role for wild-type nsP2 in inhibiting
IFN production. To examine whether KUN NS2A may have a
similar function, HEp-2 cells stably expressing KUN replicons
with the wt or mutated (Ala30-to-Pro) NS2A were transfected
with a reporter plasmid, pIF(	125/72)Lucter (31), carrying
the luciferase gene under the control of the IFN- promoter,
and luciferase expression was determined 55 h after transfec-
tion. HEp-2 cells stably transfected with a replicon containing
a mutated NS2A gene exhibited a high level of luciferase
expression that was 6- to 7-fold greater than that observed in
cells stably transfected with wt replicon RNA (Fig. 6A), thus
clearly demonstrating a role for wt NS2A in the inhibition of
IFN- promoter-driven transcriptional activation in response
to KUN replicon RNA replication. To confirm the results
obtained with HEp-2 cells stably transfected with replicon
RNAs, we performed similar studies with Vero cells transiently
expressing replicon RNAs after infection with replicon VLPs.
The results were similar (Fig. 6B), although the difference in
luciferase expression between the wt and the mutated NS2A-
encoding replicons was not as profound in transiently trans-
fected cells as it was in stably transfected cells (Fig. 6). Nev-
ertheless, 
50% inhibition of IFN- promoter-driven
transcription was achieved in replicon VLP-infected cells. Fac-
tors that could contribute to a less profound difference in
IFN- promoter-driven transcription in cells transiently trans-
fected with replicon RNAs than in stably transfected cells may
include a lower percentage of replicon-expressing cells (85
versus 100%), a shorter period of replicon RNA replication
and expression (16 versus 55 h), and a possible difference
between the IFN- promoter-driven transcription efficiencies
in Hep2 cells (stable expression) and Vero cells (transient
expression). Note that in both stably and transiently trans-
fected cells the corresponding replication and expression effi-
ciencies in the wt and the NS2A-mutated replicon RNAs were
similar within the same experiment (Fig. 6).
Individually expressed wt but not mutated NS2A protein
inhibits activation of IFN- promoter-driven transcription. To
determine the abilities of individually expressed wt NS2A pro-
tein and NS2A protein with an Ala30-to-Pro mutation to in-
hibit activation of IFN- promoter-driven transcription, we
cloned corresponding gene cassettes into the pcDNA3 vector.
In order to allow proper translocation of NS2A across the
membrane of the endoplasmic reticulum and its proper release
from the preceding NS1 protein (7), wt and mutated NS2A
genes were expressed as cassettes with the signal sequence for
the NS1 protein followed by a large deletion of 295 amino
acids, leaving intact the first 3 and the last 50 codons of NS1 (as
in dNS1.1 [26]) and the full-length NS2A gene with the addi-
tion of a C-terminal c-Myc tag. In previous studies, KUN RNA
with this coding deletion of 295 amino acids in the NS1 protein
FIG. 6. Activation of IFN- promoter-driven transcription in cells stably or transiently expressing KUN replicon RNAs with the wild-type or
the mutated (Ala30 to Pro) NS2A proteins. (A) Normal HEp-2 cells and HEp-2 cells stably expressing wild-type or NS2A-mutated KUN replicon
RNAs were transfected with an IFN- promoter-controlled luciferase reporter gene plasmid, pIF(	125/72)Lucter (31), and the pGreen
Lantern-1 control plasmid (Invitrogen). Fifty-five hours after transfection, the cells were analyzed for luciferase expression to detect activation of
IFN- promoter-controlled transcription, for green fluorescent protein (GFP) fluorescence by fluorescence-activated cell sorting to normalize
luciferase expression between transfected samples, and for -galactosidase expression to compare replication and expression efficiencies of replicon
RNAs. The error bars represent standard deviations calculated from the luciferase or -galactosidase expression determined in two wells used for
each assay. (B) Vero cells were transfected with the above-mentioned plasmids and, 32 h after transfection, were infected with KUN VLPs
containing packaged wt or NS2A-mutated replicon RNAs. Twenty hours after infection, the cells were assayed for luciferase activity, GFP
fluorescence, and -galactosidase expression as in panel A. The solid bars represent luciferase expression, and the open bars represent -galac-
tosidase expression.
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was efficiently complemented in BHK cells stably expressing
KUN replicon RNA as a helper (26), suggesting that proper
processing of the NS1-NS2A cassette occurred in these exper-
iments. Plasmid DNAs expressing wt and mutated NS2A gene
cassettes were cotransfected with the IFN- promoter reporter
plasmid pIF(	125/72)Lucter into Vero cells, which are
normally defective in IFN- synthesis (36). IFN- promoter-
driven transcription was activated by SFV infection with an
MOI of 10 32 h after transfection, and the cells were analyzed
for luciferase expression 16 h later. The results clearly showed
that in cells expressing wt NS2A, IFN- promoter-driven tran-
scription was strongly inhibited (by 7- to 8-fold) compared to
that in the control cells transfected with pcDNA3 vector DNA
(Fig. 7A). In contrast, expression of mutated NS2A did not
inhibit activation of IFN- promoter-driven transcription in
response to SFV infection (Fig. 7A). Both wt and mutated
NS2A proteins were expressed at similar levels and processed
correctly, as judged by immunofluorescence (Fig. 7B) and
Western blot (Fig. 7C) analyses using monoclonal antibodies
to the c-Myc tag. The results clearly demonstrate for the first
time a role for the flavivirus NS2A protein in inhibition of the
activation of IFN- promoter-driven transcription.
DISCUSSION
We have described identification of the adaptive mutations
in the KUN NS2A gene that allow more efficient establishment
of noncytopathic, persistent replication of KUN replicon RNA
in different cell lines. A replicon with the Ala30-to-Pro adap-
tive mutation in NS2A was 2- to 5-fold more efficient than a
replicon with the Asn101-to-Asp adaptive mutation and 15- to
50-fold more efficient than the original wild-type replicon RNA
in establishing persistent replication in BHK, HEK293, and
HEp-2 cells. Comparison of the abilities of cells stably express-
ing KUN replicon RNAs to induce IFN- promoter-driven
transcription with those of cells expressing the wild-type NS2A
or the NS2A/A30P mutant genes demonstrated for the first
time a role for the flavivirus (wild-type) NS2A in inhibition of
IFN- promoter-driven transcription. Finally, the role of
NS2A in inhibition of IFN- promoter-driven transcription
was confirmed by showing that the activation of IFN- pro-
moter-directed transcription of a reporter gene in response to
SFV infection was strongly inhibited by the individually ex-
pressed wt NS2A, whereas expression of the NS2A/A30P mu-
tant protein had no such inhibitory effect.
Adaptive mutations, RNA replication, and cytopathicity. It
was shown for the highly cytopathic alphavirus replicons that
adaptation of their replication to particular cell lines using
antibiotic-selectable replicons led to generation of mutations
that when introduced into the original replicons conferred
significant advantage in establishing noncytopathic, persistent
replication (1, 13, 39). All the adaptive mutations in Sindbis
virus and SFV replicons were located in the nsP2 protein, with
some of them down-regulating RNA replication and others
not. Selection of noncytopathic pestivirus using a similar ap-
proach (puromycin resistance) resulted in the identification of
a single-amino-acid substitution in NS4B protein; the mutation
did not down-regulate RNA replication (42). Persistent repli-
cation of hepatitis C virus (HCV) replicon RNA in Huh7 cells
also resulted in the generation of adaptive mutations located in
different nonstructural proteins; however in contrast to alpha-
virus replicons, these adaptive mutations generally enhanced
HCV replicon RNA replication (4, 34, 41, 50). It was therefore
reasonable to assume that establishment of persistent replica-
tion of KUN replicons in cells using a similar approach would
allow the selection of KUN replicons with adaptive mutations
in the nonstructural proteins. Indeed, sequencing of the entire
replicon RNA isolated from two puromycin-resistant cell
clones identified three adaptive mutations, two in NS2A and
one in NS5 (Table 1). Adaptive mutation in NS5 when intro-
duced into the original wt KUN replicon RNA only marginally
improved the ability of RNA to establish persistent replication
while resulting in dramatic down-regulation of initiation and/or
efficiency of RNA replication in transient studies. In contrast,
both adaptive mutations in NS2A provided an advantage in
establishing persistent replication while not significantly inhib-
iting the initiation and efficiency of RNA replication. Thus, it
seems likely from our results that adaptation of KUN RNA to
persistent replication may proceed without down-regulation of
KUN RNA replication.
KUN NS2A protein inhibits IFN- promoter-driven tran-
scription. Virus infections trigger a massive antiviral response
that leads to activation of a wide range of antiviral genes,
including those for IFNs. IFN- is one of the first antiviral
genes whose transcription is induced by viral infections. Tran-
scription factors involved in activation of IFN- gene transcrip-
tion may be induced by viruses through a number of different
pathways, with the interferon regulatory factor 3 (IRF-3) path-
way being the most prominent (11, 15, 22, 43). Members of the
family Flaviviridae, HCV and bovine viral diarrhea virus, have
been shown to block the IRF-3 pathway by either preventing
IRF-3 phosphorylation (HCV) (11) or directly preventing tran-
scriptional activity of phosphorylated IRF-3 (bovine viral diar-
rhea virus) (3). Most recent studies with the more closely
related flavivirus WNV (New York 2000 strain) showed direct
involvement of the IRF-3 pathway in controlling cell-to-cell
spread of the virus (12). However, the actions of the virus-
induced IRF-3 pathway were insufficient to prevent WNV rep-
lication (12). Our experiments showed that antiviral response
was severely compromised in Hep2 cells stably transfected with
KUN replicon RNA encoding the wt NS2A gene. The cells
showed a dramatic decrease in activation of the transcription
of a reporter gene from the IFN- promoter. Furthermore,
expression of wt NS2A protein alone was able to inhibit acti-
vation of transcription from the IFN- promoter in response to
exogenous virus stimulus. It is possible that wt NS2A protein
may be down-regulating IFN- promoter-driven transcription
through inhibition of one of the components of the IRF-3
pathway, thus allowing virus to escape the host antiviral re-
sponse. Alternatively, activation of other antiviral factors, such
as PKR or 2-5-oligoadenylate synthetase, may be inhibited by
the wt NS2A protein.
In contrast to our findings, recent studies with dengue virus
did not show inhibition of IFN- promoter-driven transcrip-
tion by any of the dengue virus NS proteins, including NS2A,
when they were expressed individually in 293T cells (37). It is
possible that dengue virus NS2A expressed individually from
cDNA encoding the NS2A gene alone, without the preceding
sequence from NS1 required for its proper processing (9, 10,
40), could not function properly in these assays. In our exper-
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iments, KUN NS2A was expressed as a cassette with the pre-
ceding NS1 sequences and was shown to be processed properly
to release the native NS2A protein. It is also possible that
substantial differences between the amino acid sequences of
KUN and dengue virus NS2A proteins and/or differences in
cell lines used for their expression (293T cells for dengue virus
and Vero cells for KUN) could affect the NS2A function in
inhibition of IFN- promoter-driven transcription. For exam-
ple, only a single-amino-acid change in KUN NS2A (Ala30 to
Pro) was sufficient to completely abolish its function in inhibi-
tion of the activation of transcription from the IFN- promoter
(see below). Similarly, a single-amino-acid mutation in the
simian virus 5 V protein was shown to be responsible for the
difference in its ability to block interferon signaling in human
and murine cell lines (49).
Adaptive mutations, IFN response, and persistent replica-
tion. As mentioned above, Ala30-to-Pro mutation in NS2A
completely abolished its function in inhibiting the activation of
IFN- promoter-driven transcription either when expressed
alone or in the context of KUN replicon RNA. It is not clear
how this mutation, which actually up-regulated the cellular
antiviral response by not blocking the activation of IFN-
promoter-driven transcription in response to viral-RNA repli-
cation, could provide an advantage to KUN replicon RNA in
establishing persistent replication. Studies with Sindbis virus
showed that the adaptive mutation in Sindbis virus nsP2 pro-
tein (Pro726 to Leu) that provided an advantage in establishing
persistent replication for the replicon RNA also resulted in
efficient production of IFN-/ when introduced into a Sindbis
virus infectious clone, while the wt virus was deficient in IFN-
/ production (14). Apparently, the resulting accumulation of
IFN-/ in the medium of nsP2-mutated Sindbis virus-infected
cells led to protection of neighboring uninfected cells, as well
as to down-regulation of virus replication in infected cells.
Interestingly, Pro726-to-Leu mutation in nsP2 also significantly
reduced RNA replication efficiency (13), presumably by inhib-
iting nsP2-associated activities as part of a replication complex.
Other studies with Sindbis virus and SFV replicons reported
different adaptive mutations in nsP2 that provided an advan-
tage in establishing persistent replication without affecting
RNA replication efficiency (39). Neither of the studies, how-
ever, showed the effects of these adaptive mutations on IFN-
/ production either when introduced into the replicon RNA
or when present in individually expressed nsP2 protein. It is
therefore not clear from the alphavirus replicon studies
whether the establishment of persistent (noncytopathic) repli-
cation is associated with the abilities of adaptive mutations to
alter IFN response or to simply down-regulate RNA replica-
tion or both.
Ala30-to-Pro mutation in KUN NS2A provided an advan-
tage in establishing persistent replication without inhibiting
KUN replicon RNA replication. At the same time, the muta-
tion was shown to remove the block in activation of IFN-
promoter-driven transcription characteristic of the wt NS2A
protein either in response to KUN RNA replication when
present in replicon RNA (replicon-expressing cells) or in re-
sponse to exogenous stimulus (SFV challenge) when present in
individually expressed NS2A protein. Although wt and NS2A-
mutated replicons clearly differed in their abilities to down-
regulate the activation of IFN- promoter-driven transcrip-
FIG. 7. KUN wild-type but not Ala30-to-Pro-mutated NS2A protein
inhibits the activation of IFN- promoter-driven transcription. (A) Vero
cells in 24-well plates (two wells per transfection mixture) were cotrans-
fected with an IFN- promoter-controlled luciferase reporter gene plas-
mid, pIF(	125/72)Lucter (31); the control -galactosidase-expressing
plasmid pCMV- (Invitrogen); and the plasmid pcDNA3-wtNS2A or
pcDNA3-NS2A/A30P expressing either the wild-type NS2A gene or the
Ala30-to-Pro-mutated NS2A gene, respectively. Forty hours after trans-
fection, the cells were infected with SFV at an MOI of 10 for 16 h and
lysed to determine luciferase activity. The activation of IFN- promoter-
driven transcription is shown as induction of luciferase expression in
SFV-infected cells relative to luciferase expression in uninfected cells. The
error bars represent standard deviations calculated from the luciferase
expression determined in two wells used for the luciferase assay. Lucif-
erase expression was normalized to the expression of -galactosidase from
the cotransfected pCMV- plasmid. (B and C) Vero cells were trans-
fected with pcDNA3 plasmids expressing the wt NS2A and NS2A/A30P
mutant proteins fused to the c-Myc epitope. Forty-eight hours after trans-
fection, the cells were either fixed with cold acetone and used in indirect
immunofluorescence analysis with anti-c-Myc monoclonal antibodies (21)
or lysed and assayed for expression of NS2A–c-Myc fusion proteins by
Western blot analysis with the ECL Plus Western-blotting kit (Amersham
Biosciences, Castle Hill, New South Wales, Australia) essentially as de-
scribed by the manufacturer. Control in panel C represents a sample from
untransfected Vero cells.
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tion, the antiviral activities of IFN-/ were inhibited with
similar efficiencies in cells stably expressing wt and NS2A-
mutated replicons (W. J. Liu and A. A. Khromykh, unpub-
lished results). It was shown recently that once established,
KUN replicon RNA replication was resistant to the antiviral
activity of IFN- (16). Most recently, it has also been shown
that KUN and WNV blocked IFN-/ signaling (W. J. Liu,
X. J. Wang, V. V. Mokhonov, P.-Y. Shi, R. Randall, and A. A.
Khromykh, submitted for publication). Therefore, any increase
in the amount of IFN-/ produced as a consequence of up-
regulated IFN- promoter-driven transcription by NS2A-mu-
tated replicon RNA should not affect ongoing replication of
replicon RNA. Hence, it is possible that the effect of an adap-
tive mutation(s) in NS2A on IFN response may not be related
to the more efficient establishment of persistent replication,
and thus the decreased cytopathicity of NS2A-mutated KUN
replicon RNA may be caused by other mechanisms. These may
include inhibition of double-stranded-RNA-induced apoptosis
and reduction in NS2A cytotoxicity (6). Clearly, further studies
are required to elucidate the mechanisms allowing flavivirus
replicon RNAs to establish persistent (noncytopathic) replica-
tion.
It is becoming apparent that removing or mutating the genes
in RNA viruses responsible for inhibition of IFN production or
signaling leads to significant virus attenuation, and this ap-
proach has been employed in developing a number of safe
vaccine candidates (5, 8). It is therefore likely that incorpora-
tion of the Ala30-to-Pro mutation in KUN NS2A that abol-
ishes NS2A activity in inhibition of the antiviral response will
lead to further attenuation of KUN and thus provide the basis
for an even safer infectious KUN DNA-based vaccine against
the New York strain of WNV (18). Studies to determine the in
vivo effects of Ala30-to-Pro mutation in NS2A on the attenu-
ation and efficacy of infectious KUN DNA-based WNV vac-
cine are under way.
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